Tune into this episode of the podcast to hear from Ben Lightburn, the Co-Founder & CEO of Filament Health.
Listed on the NEO Exchange, Filament Health have many irons in the psychedelic fire, spearheading clinical trials (alongside the University of California, San Francisco), registering a whole host of IP and making strides forward within drug discovery.
As a company that favours naturally derived psychedelics, rather than their synthetic counterparts, this is a must listen for anyone with a keen eye on psychedelic medicine!
You can check out other podcasts on the GCI Content Hub by clicking here.
Alternatively, you can subscribe to the podcast on Apple/iTunes, Spotify and other podcasting apps!
